Evidence map›Paper›PMID 21695616›Full record

ReviewFrontiers of medicine2011

Developments in cancer prevention and treatment using traditional Chinese medicine.

Hongsheng Lin, Jie Liu, Ying Zhang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Frontiers of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Ren Shen Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/II Open-Label Study.Journal of alternative and complementary medicine (New York, N.Y.) · 2015
    Trial
  4. Article
  5. Review
  6. Frontiers in oncology · 2024
    Review
  7. Article
  8. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Review
  9. Article
  10. Effects of a Chlorogenic Acid-Containing Herbal Medicine (LASEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  11. Ethanol Extracts ofJournal of immunology research · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hongsheng LinDepartment of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. drlinhongsheng@163.com
Jie Liu
Ying Zhang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Through the joint efforts of several generations of practitioners in traditional Chinese medicine (TCM) and integrated medicine of oncology, we have made some achievements in cancer treatment using TCM in over 50 years, including treatment concepts, methods, and basic and clinical research. Currently, TCM plays an indispensable role in cancer prevention and treatment. However, we also clearly recognize that there are some issues that have yet to be resolved. In the future, cancer treated with TCM will face unprecedented opportunities and challenges. This article reviews the developments of TCM in the treatment of cancer.

Indexed as

Integrative MedicineMedicine, Chinese TraditionalAnticarcinogenic AgentsAntineoplastic AgentsChinaCytotoxinsHerbal MedicineHumansImmune SystemIncidenceNeoplasmsAnticarcinogenic AgentsAntineoplastic AgentsCytotoxins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.